Terns Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Terns Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2019 to Q4 2023.
  • Terns Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $7.51M, a 18.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $7.51M +$1.19M +18.8% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $6.32M +$467K +7.98% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $5.85M +$443K +8.2% Dec 31, 2021 10-K 2024-03-14
Q4 2020 $5.41M +$697K +14.8% Dec 31, 2020 10-K 2023-03-27
Q4 2019 $4.71M Dec 31, 2019 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.